: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Head and Neck Cancer

Free Subscription

Articles published in BMC Cancer
Retrieve available abstracts of 470 articles:
HTML format

Single Articles

May 2024

RONG Y, Hao Y, Wei D, Li Y, et al
Association between preoperative anxiety states and postoperative complications in patients with esophageal cancer and COPD: a retrospective cohort study.
BMC Cancer. 2024;24:606.
PubMed Abstract available

DU R, Fan S, Yang D, Wang X, et al
Exploration of lymph node recurrence patterns and delineation guidelines of radiation field in middle thoracic oesophageal carcinomas after radical surgery: a real-world study.
BMC Cancer. 2024;24:596.
PubMed Abstract available

LIU H, Li K, Xia J, Zhu J, et al
Prediction of esophageal cancer risk based on genetic variants and environmental risk factors in Chinese population.
BMC Cancer. 2024;24:598.
PubMed Abstract available

PAN Y, Chen Z, Hong W, Huang Z, et al
A nomogram based on nutritional and inflammatory parameters to predict DMFS and identify beneficiaries of adjuvant chemotherapy in IVA-stage nasopharyngeal carcinoma.
BMC Cancer. 2024;24:578.
PubMed Abstract available

WU WB, Cai WL, Zou YH, You R, et al
Outcomes of patients in nasopharyngeal adenoid cystic carcinoma in the IMRT era: a single-center experience.
BMC Cancer. 2024;24:576.
PubMed Abstract available

ZHANG X, Sun K, Gan R, Yan Y, et al
WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical beta-catenin pathway.
BMC Cancer. 2024;24:564.
PubMed Abstract available

HUANG S, Zhang J, He P, Cui X, et al
Radiation-induced upregulation of FGL1 promotes esophageal squamous cell carcinoma metastasis via IMPDH1.
BMC Cancer. 2024;24:557.
PubMed Abstract available

April 2024

VIANA VELOSO GG, Amaral FD, Nogueira-Rodrigues A
Impact of COVID-19 pandemic among patients with lung and head and neck cancer assisted in a public cancer center in Brazil.
BMC Cancer. 2024;24:539.
PubMed Abstract available

LI C, Li M, Wei W, Wang Z, et al
Association of DOK3 and infiltrated tumor-associated macrophages with risk for the prognosis of Porphyromonas gingivalis-infected oral cancer: a 12-year data analysis of 200 patients from a tertiary teaching hospital, Urumqi, China.
BMC Cancer. 2024;24:534.
PubMed Abstract available

DONG Z, Wang GY, Dai DY, Qin GJ, et al
Correction: Prognostic value of pre-treatment [(18)F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis.
BMC Cancer. 2024;24:528.
PubMed

JIANG T, Chen C, Zhou Y, Cai S, et al
Deep learning-assisted diagnosis of benign and malignant parotid tumors based on ultrasound: a retrospective study.
BMC Cancer. 2024;24:510.
PubMed Abstract available

SHEN J, Ma Z, Yang J, Qu T, et al
CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p/PKM2 axis.
BMC Cancer. 2024;24:511.
PubMed Abstract available

JOHANSSON B, Cajander A, Ahmad A, Ohlsson-Nevo E, et al
The effect of internet-administered support (carer eSupport) on preparedness for caregiving in informal caregivers of patients with head and neck cancer compared with support as usual: a study protocol for a randomized controlled trial.
BMC Cancer. 2024;24:494.
PubMed Abstract available

CIRILLO A, Marinelli D, Romeo U, Messineo D, et al
Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
BMC Cancer. 2024;24:487.
PubMed

CHEN Y, Huang Y, Chen X, Chen Z, et al
Efficacy of salvage surgery versus re-irradiation for isolated regional lymph node recurrence in patients with nasopharyngeal carcinoma.
BMC Cancer. 2024;24:483.
PubMed Abstract available

MALEKI Z, Hassanzadeh J, Ghaem H
Correlation between socioeconomic indices and epidemiological indices of thyroid cancer from 1990 to 2019 year: a global ecologic study.
BMC Cancer. 2024;24:467.
PubMed Abstract available

DONG Z, Wang GY, Dai DY, Qin GJ, et al
Prognostic value of pre-treatment [(18)F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis.
BMC Cancer. 2024;24:466.
PubMed Abstract available

ELTOHAMI Y, Suleiman A
Survival analysis of Sudanese oral squamous cell carcinoma patients with field of cancerization.
BMC Cancer. 2024;24:473.
PubMed Abstract available

MAN Q, Li P, Fan J, Yang S, et al
The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy.
BMC Cancer. 2024;24:464.
PubMed Abstract available

YANG Y, Yi Y, Wang Z, Li S, et al
A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.
BMC Cancer. 2024;24:460.
PubMed Abstract available

IDEL C, Fleckner J, Plotze-Martin K, Werner L, et al
Partial recovery of peripheral blood monocyte subsets in head and neck squamous cell carcinoma patients upon radio(chemo)therapy is associated with decreased plasma CXCL11.
BMC Cancer. 2024;24:459.
PubMed Abstract available

DEUTSCH F, Sais D, Keatinge N, Hill M, et al
Biplex quantitative PCR to detect transcriptionally active human papillomavirus 16 from patient saliva.
BMC Cancer. 2024;24:442.
PubMed Abstract available

ROUTILA E, Mahran R, Salminen S, Irjala H, et al
Identification of stemness-related glycosylation changes in head and neck squamous cell carcinoma.
BMC Cancer. 2024;24:443.
PubMed Abstract available

CAO X, Wang X, Song J, Su Y, et al
Pretreatment multiparametric MRI radiomics-integrated clinical hematological biomarkers can predict early rapid metastasis in patients with nasopharyngeal carcinoma.
BMC Cancer. 2024;24:435.
PubMed Abstract available

CIRILLO A, Marinelli D, Romeo U, Messineo D, et al
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
BMC Cancer. 2024;24:430.
PubMed Abstract available

WANG H, Zhang C, Li Q, Tian T, et al
Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches.
BMC Cancer. 2024;24:427.
PubMed Abstract available

CHEN W, Lin G, Chen Y, Cheng F, et al
Prediction of the Ki-67 expression level in head and neck squamous cell carcinoma with machine learning-based multiparametric MRI radiomics: a multicenter study.
BMC Cancer. 2024;24:418.
PubMed Abstract available

AWNY S, Abdallah A, Metwally IH, Abdelwahab K, et al
Impact of age on central lymph nodes involvement in papillary thyroid cancer.
BMC Cancer. 2024;24:423.
PubMed Abstract available

LI J, Gao X, Sun X, Li H, et al
Investigating the causal role of the gut microbiota in esophageal cancer and its subtypes: a two-sample Mendelian randomization study.
BMC Cancer. 2024;24:416.
PubMed Abstract available

AVRY F, Roseau C, Leguay Z, Brabant S, et al
Evaluation of a new score associated with acute kidney injury in patients treated with cisplatin based EXTREME regimen.
BMC Cancer. 2024;24:405.
PubMed Abstract available

KRIELLAARS Y, Vermaire JA, Beugeling M, Poorter R, et al
The effect of physical exercise during radiotherapy on physical performance in patients with head and neck cancer: a trial within cohorts study protocol, the vital study.
BMC Cancer. 2024;24:403.
PubMed Abstract available

March 2024

CUI C, Wang L, Wang X
Effects of physical and psychological symptoms on cancer-related fatigue among esophageal cancer patients.
BMC Cancer. 2024;24:398.
PubMed Abstract available

CHEN Y, Yin M, Zhang Y, Zhou N, et al
Imprinted gene detection effectively improves the diagnostic accuracy for papillary thyroid carcinoma.
BMC Cancer. 2024;24:359.
PubMed Abstract available

DAVAATSEND O, Altannamar M, Ganbat M, Jagdagsuren U, et al
Factors associated with recurrence in patients with oral cancer in Mongolia.
BMC Cancer. 2024;24:356.
PubMed Abstract available

FAN C, Wang X, Zheng X, Sun Y, et al
Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial.
BMC Cancer. 2024;24:321.
PubMed Abstract available

KHANNA D, Sharma P, Budukh A, Vishwakarma R, et al
Rural-urban disparity in cancer burden and care: findings from an Indian cancer registry.
BMC Cancer. 2024;24:308.
PubMed Abstract available

FUKUDA H, Uehara T, Nakajima T, Iwaya M, et al
A preliminary study of IgG4 expression and its prognostic significance in oral squamous cell carcinoma.
BMC Cancer. 2024;24:294.
PubMed Abstract available

February 2024

HU Z, Wang L, Lu M, Yang W, et al
Protect the recurrent laryngeal nerves in US-guided microwave ablation of thyroid nodules at Zuckerkandl tubercle: a pilot study.
BMC Cancer. 2024;24:271.
PubMed Abstract available

ZHENG T, Wang L, Wang H, Tang L, et al
Prediction model based on MRI morphological features for distinguishing benign and malignant thyroid nodules.
BMC Cancer. 2024;24:256.
PubMed Abstract available

GONG L, Li P, Liu J, Liu Y, et al
A nomogram for predicting adverse pathologic features in low-risk papillary thyroid microcarcinoma.
BMC Cancer. 2024;24:244.
PubMed Abstract available

YANG Y, Tan H, Lu Y, Mei J, et al
Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma.
BMC Cancer. 2024;24:249.
PubMed Abstract available

HUANG X, Chen X, Wan G, Yang D, et al
Mechanism of intestinal microbiota disturbance promoting the occurrence and development of esophageal squamous cell carcinoma--based on microbiomics and metabolomics.
BMC Cancer. 2024;24:245.
PubMed Abstract available

DE MORAES FCA, Pasqualotto E, Chavez MP, Ferreira ROM, et al
Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials.
BMC Cancer. 2024;24:240.
PubMed Abstract available

QIU P, Guo Q, Pan K, Lin J, et al
Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma.
BMC Cancer. 2024;24:235.
PubMed Abstract available

YASSIN-KASSAB A, Chatterjee S, Khan N, Wang N, et al
p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer.
BMC Cancer. 2024;24:233.
PubMed Abstract available

YU XW, She PW, Chen FC, Chen YY, et al
Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies.
BMC Cancer. 2024;24:230.
PubMed Abstract available

TAN R, Zhu X, Sun Y, Yang S, et al
The association of HBV infection and head and neck cancer: a systematic review and meta-analysis.
BMC Cancer. 2024;24:225.
PubMed Abstract available

ALMANGUSH A, Hagstrom J, Haglund C, Kowalski LP, et al
The prognostic role of single cell invasion and nuclear diameter in early oral tongue squamous cell carcinoma.
BMC Cancer. 2024;24:213.
PubMed Abstract available

JAKSTAS T, Bartnykaite A, Padervinskis E, Vegiene A, et al
The association of E2F1 and E2F2 single nucleotide polymorphisms with laryngeal squamous cell carcinoma pathomorphological features.
BMC Cancer. 2024;24:214.
PubMed Abstract available

WU Y, Chen W, Miao H, Xu T, et al
SIRT7 promotes the proliferation and migration of anaplastic thyroid cancer cells by regulating the desuccinylation of KIF23.
BMC Cancer. 2024;24:210.
PubMed Abstract available

ZHU Z, Wang W, Zha Y, Wang X, et al
Development and validation of a nomogram for predicting overall survival in patients with sinonasal mucosal melanoma.
BMC Cancer. 2024;24:184.
PubMed Abstract available

LU RD, Wei ZD, Liu YX, Tian D, et al
Increased resected lymph node stations improved survival of esophageal squamous cell carcinoma.
BMC Cancer. 2024;24:177.
PubMed Abstract available

January 2024

WEI B, Yao J, Peng C, Zhao S, et al
Correction: Clinical features and imaging examination assessment of cervical lymph nodes for thyroid carcinoma.
BMC Cancer. 2024;24:145.
PubMed

SAKAMOTO K, Hiraoka SI, Kawamura K, Ruan P, et al
Automated evaluation of masseter muscle volume: deep learning prognostic approach in oral cancer.
BMC Cancer. 2024;24:128.
PubMed Abstract available

ZHANG Y, Du H, Wang N, Wang L, et al
An update of clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta-analysis.
BMC Cancer. 2024;24:129.
PubMed Abstract available

LV T, Liu H, Mao L, Song Y, et al
Cancer-associated fibroblast-derived extracellular vesicles promote lymph node metastases in oral cavity squamous cell carcinoma by encapsulating ITGB1 and BMI1.
BMC Cancer. 2024;24:113.
PubMed Abstract available

PAN XB, Lu Y, Wei YS, Yao DS, et al
Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma.
BMC Cancer. 2024;24:106.
PubMed Abstract available

VAN BEERS MA, Speksnijder CM, van Gils CH, Frederix GWJ, et al
Prophylactic pectoralis major flap to compensate for increased risk of pharyngocutaneous fistula in laryngectomy patients with low skeletal muscle mass (PECTORALIS): study protocol for a randomized controlled trial.
BMC Cancer. 2024;24:76.
PubMed Abstract available

GAO Y, Wang W, Yang Y, Xu Z, et al
An integrated model incorporating deep learning, hand-crafted radiomics and clinical and US features to diagnose central lymph node metastasis in patients with papillary thyroid cancer.
BMC Cancer. 2024;24:69.
PubMed Abstract available

GHASEMIAN A, Sargeran K, Khami MR, Shamshiri AR, et al
Effects of educational interventions based on the theory of planned behavior on oral cancer-related knowledge and tobacco smoking in adults: a cluster randomized controlled trial.
BMC Cancer. 2024;24:45.
PubMed Abstract available

LIU Q, Yuan Y, Shang X, Xin L, et al
Cyclin B2 impairs the p53 signaling in nasopharyngeal carcinoma.
BMC Cancer. 2024;24:25.
PubMed Abstract available

WANG C, Hou Y, Wang L, Yang Y, et al
Analysis of correlative risk factors for radiation-induced hypothyroidism in head and neck tumors.
BMC Cancer. 2024;24:5.
PubMed Abstract available

YU K, Liu S, Lin Z, Song J, et al
Effect of trace element mixtures on the outcome of patients with esophageal squamous cell carcinoma: a prospective cohort study in Fujian, China.
BMC Cancer. 2024;24:24.
PubMed Abstract available

December 2023

XU H, Li W, Zhang H, Wang H, et al
Preliminary evidence for endoscopic surgery combined with postoperative anti-PD-1 immunotherapy in advanced recurrent nasopharyngeal carcinoma.
BMC Cancer. 2023;23:1259.
PubMed Abstract available

XING J, Gu Y, Song Y, Liu Q, et al
MYO5A overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma.
BMC Cancer. 2023;23:1267.
PubMed Abstract available

ZHOU J, Wei S, Guo X, Huang Y, et al
Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma.
BMC Cancer. 2023;23:1247.
PubMed Abstract available

PARK HC, Kim H, Kim JY, Lee HY, et al
PSMD1 as a prognostic marker and potential target in oropharyngeal cancer.
BMC Cancer. 2023;23:1242.
PubMed Abstract available

DING C, Guo Y, Zhou Y, He Y, et al
Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial).
BMC Cancer. 2023;23:1237.
PubMed Abstract available

CHE J, Zhao Y, Gu B, Li S, et al
Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer.
BMC Cancer. 2023;23:1238.
PubMed Abstract available

WEI B, Yao J, Peng C, Zhao S, et al
Clinical features and imaging examination assessment of cervical lymph nodes for thyroid carcinoma.
BMC Cancer. 2023;23:1225.
PubMed Abstract available

ZHAO J, Zhang S, Guo X, Li C, et al
PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis.
BMC Cancer. 2023;23:1221.
PubMed Abstract available

WU S, Yuan X, Huang H, Li Y, et al
Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma.
BMC Cancer. 2023;23:1217.
PubMed Abstract available

HELENE C, Conrad O, Pflumio C, Borel C, et al
Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study.
BMC Cancer. 2023;23:1209.
PubMed Abstract available

WANG YJ, Xie XF, He YQ, Bao T, et al
Impact of perioperative decreased serum albumin level on anastomotic leakage in esophageal squamous cell carcinoma patients treated with neoadjuvant chemotherapy followed by minimally invasive esophagectomy.
BMC Cancer. 2023;23:1212.
PubMed Abstract available

GAO J, Lan J, Liao H, Yang F, et al
Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges.
BMC Cancer. 2023;23:1205.
PubMed Abstract available

ZHENG J, Zhang H, Li S, Kang Z, et al
Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
BMC Cancer. 2023;23:1193.
PubMed Abstract available

November 2023

LUO J, Xiao W, Hua F, Cao Y, et al
Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis.
BMC Cancer. 2023;23:1172.
PubMed Abstract available

ZHOU Q, He Q, He W, Wang C, et al
Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study.
BMC Cancer. 2023;23:1171.
PubMed Abstract available

GIOTAKIS AI, Runge A, Dudas J, Glueckert R, et al
Analysis of cells of epithelial, connective tissue and immune differentiation in HPV-positive-, HPV-negative oropharyngeal carcinoma and normal oropharyngeal tissue by immunofluorescence multiplex image cytometry: a preliminary report.
BMC Cancer. 2023;23:1154.
PubMed Abstract available

CUI L, Chen Z, Zeng F, Jiang X, et al
Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinoma.
BMC Cancer. 2023;23:1146.
PubMed Abstract available

YANG Z, Zuo Q, Liu R, Wu H, et al
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study.
BMC Cancer. 2023;23:1140.
PubMed Abstract available

CHEN C, Liu Y, Yao J, Wang K, et al
Deep learning approaches for differentiating thyroid nodules with calcification: a two-center study.
BMC Cancer. 2023;23:1139.
PubMed Abstract available

WANG H, Zhou Z, Lin W, Qian Y, et al
MicroRNA-21 promotes head and neck squamous cell carcinoma (HNSCC) induced transition of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
BMC Cancer. 2023;23:1135.
PubMed Abstract available

ZHENG H, Yin X, Pan T, Tao X, et al
Effect of different surgical approaches on the survival and safety of Siewert type II esophagogastric junction adenocarcinoma: a systematic review and meta-analysis.
BMC Cancer. 2023;23:1130.
PubMed Abstract available

XU T, Zhu C, Song F, Zhang W, et al
Immunological characteristics of immunogenic cell death genes and malignant progression driving roles of TLR4 in anaplastic thyroid carcinoma.
BMC Cancer. 2023;23:1131.
PubMed Abstract available

HU J, Yan J, Chen Y, Li X, et al
ESCO2 promotes hypopharyngeal carcinoma progression in a STAT1-dependent manner.
BMC Cancer. 2023;23:1114.
PubMed Abstract available

SIJBEN J, Rainey L, Peters Y, Fitzgerald RC, et al
Dutch, UK and US professionals' perceptions of screening for Barrett's esophagus and esophageal adenocarcinoma: a concept mapping study.
BMC Cancer. 2023;23:1111.
PubMed Abstract available

ROUSSOT N, Fumet JD, Limagne E, Thibaudin M, et al
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
BMC Cancer. 2023;23:1080.
PubMed Abstract available

WANG X, Yu Y, Ji Y, Ma Z, et al
Clinical characteristics and therapeutic response of differentiated thyroid carcinoma with obesity and diabetes.
BMC Cancer. 2023;23:1077.
PubMed Abstract available

YOKOTA T, Zenda S, Kodaira T, Kiyota N, et al
Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III
BMC Cancer. 2023;23:1068.
PubMed Abstract available

XU X, Wang W, Tian B, Zhang X, et al
The predicting role of serum tumor-specific growth factor for prognosis of esophageal squamous cell carcinoma.
BMC Cancer. 2023;23:1067.
PubMed Abstract available

KLASEN C, Wuerdemann N, Rothbart P, Prinz J, et al
Sex-specific aspects in patients with oropharyngeal squamous cell carcinoma: a bicentric cohort study.
BMC Cancer. 2023;23:1054.
PubMed Abstract available

SUGAWARA K, Oka D, Hara H, Yoshii T, et al
Survival outcomes of esophageal cancer patients with recurrence after curative treatments.
BMC Cancer. 2023;23:1051.
PubMed Abstract available

October 2023

ZHANG L, Zhou M, Gao X, Xie Y, et al
Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity.
BMC Cancer. 2023;23:1048.
PubMed Abstract available

TSUCHIHASHI K, Ito M, Arita S, Kusaba H, et al
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.
BMC Cancer. 2023;23:1046.
PubMed Abstract available

NATSUKI S, Tanaka H, Nishiyama M, Deguchi S, et al
Significance of CD103(+) tissue-resident memory T cells for predicting the effectiveness of immune checkpoint inhibitors in esophageal cancer.
BMC Cancer. 2023;23:1011.
PubMed Abstract available

LAU HC, Yuan X, Huang H, Zhang M, et al
Fusobacterium nucleatum facilitates proliferation and autophagy by activating miR-361-3p/NUDT1 axis through oxidative stress in hypopharyngeal squamous cell carcinoma.
BMC Cancer. 2023;23:990.
PubMed Abstract available

SHENG L, Zhuang L, Yang J, Zhang D, et al
Radiation pneumonia predictive model for radiotherapy in esophageal carcinoma patients.
BMC Cancer. 2023;23:988.
PubMed Abstract available

MODESTO A, Tougeron D, Tremolieres P, Ronchin P, et al
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol.
BMC Cancer. 2023;23:966.
PubMed Abstract available

NIU X, Liu P, Wang X, Hu C, et al
Is radical radiotherapy with/without surgery an effective treatment in the lymphoepithelial carcinoma of the salivary gland?.
BMC Cancer. 2023;23:968.
PubMed Abstract available

ZHAO Z, Sun Y, Tang J, Yang Y, et al
LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells.
BMC Cancer. 2023;23:935.
PubMed Abstract available

September 2023

SAFI S, Ahmadzade M, Karimi S, Akbari ME, et al
A registration trend in eyelid skin cancers and associated risk factors in Iran, 2005-2016.
BMC Cancer. 2023;23:924.
PubMed Abstract available

WANG M, Gao M, Chen Y, Wu J, et al
PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling.
BMC Cancer. 2023;23:921.
PubMed Abstract available

MA X, Pierce E, Anand H, Aviles N, et al
Early prediction of response to palliative chemotherapy in patients with stage-IV gastric and esophageal cancer.
BMC Cancer. 2023;23:910.
PubMed Abstract available

HUANG Q, Chen J, Huang Y, Xiong Y, et al
The prognostic role of coagulation markers in the progression and metastasis of laryngeal squamous cell carcinoma.
BMC Cancer. 2023;23:901.
PubMed Abstract available

ZHANG Y, Chen Y, Chen R, Zhou H, et al
YTHDF3as a prognostic predictive biomarker of thyroid cancer and its correlation with immune infiltration.
BMC Cancer. 2023;23:882.
PubMed Abstract available

XU S, Huang H, Dong H, Wang X, et al
Association between surgical extent and recurrence in unilateral intermediate- to high-risk papillary thyroid cancer.
BMC Cancer. 2023;23:880.
PubMed Abstract available

LI C, Guan R, Li W, Wei D, et al
Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC.
BMC Cancer. 2023;23:840.
PubMed Abstract available

DING A, Lv H, Cao J, Wang X, et al
Ultrasonography characteristics of cystic components in primary salivary gland tumors.
BMC Cancer. 2023;23:833.
PubMed Abstract available

SONG D, Ye Z, Chen F, Zhan L, et al
circFNDC3B promotes esophageal squamous cell carcinoma progression by targeting MYO5A via miR-370-3p/miR-136-5p.
BMC Cancer. 2023;23:821.
PubMed Abstract available

August 2023

XIE W, Sun G, Xia J, Chen H, et al
Identification of novel tumor-associated antigens and evaluation of a panel of autoantibodies in detecting oral cancer.
BMC Cancer. 2023;23:802.
PubMed Abstract available

MIN X, Zhang Z, Chen Y, Zhao S, et al
Comparison of the effectiveness of lauromacrogol injection for ablation and microwave ablation in the treatment of predominantly cystic thyroid nodules: a multicentre study.
BMC Cancer. 2023;23:785.
PubMed Abstract available

WANG X, Sun H, Li L, Gan Z, et al
Changing patterns of nasopharyngeal carcinoma incidence in Hong Kong: a 30-year analysis and future projections.
BMC Cancer. 2023;23:761.
PubMed Abstract available

FLOUD S, Hermon C, Simpson RF, Reeves GK, et al
Alcohol consumption and cancer incidence in women: interaction with smoking, body mass index and menopausal hormone therapy.
BMC Cancer. 2023;23:758.
PubMed Abstract available

NAAKKA E, Wahbi W, Tiikkaja R, Juurikka K, et al
Novel human lymph node-derived matrix supports the adhesion of metastatic oral carcinoma cells.
BMC Cancer. 2023;23:750.
PubMed Abstract available

LIN L, Almont T, Beaubrun M, Macni J, et al
Overall survival of patients with thyroid cancer in Martinique (2008-2018).
BMC Cancer. 2023;23:739.
PubMed Abstract available

LIU Y, Han Y, Liu F, Hu D, et al
Involved site radiation therapy in stage I-III nasopharyngeal carcinoma with limited lymph node burden (ISRT-NPC) or elective region irradiation: a study protocol for a multicenter non-inferiority randomized controlled phase III clinical trial.
BMC Cancer. 2023;23:724.
PubMed Abstract available

HUANG H, Xu S, Ni S, Wang X, et al
A nomogram for predicting lateral lymph node metastasis in cN0 unifocal papillary thyroid microcarcinoma.
BMC Cancer. 2023;23:718.
PubMed Abstract available

July 2023

HUANG X, Chen Y, Yang H, Wang R, et al
Preoperative serum bilirubin is an independent prognostic factor for curatively resected esophageal squamous cell carcinoma.
BMC Cancer. 2023;23:706.
PubMed Abstract available

DU Q, Wu X, Zhang K, Cao F, et al
Correction: Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma.
BMC Cancer. 2023;23:697.
PubMed

LIU H, Jiang M, Ma F, Qin J, et al
JMJD6 functions as an oncogene and is associated with poor prognosis in esophageal squamous cell carcinoma.
BMC Cancer. 2023;23:696.
PubMed Abstract available

TIAN D, Jiang KY, Yang YS, Yan HJ, et al
Pararespiratory and paradigestive lymph node metastases in esophageal squamous cell carcinoma: predicting survival and refining the N staging system.
BMC Cancer. 2023;23:695.
PubMed Abstract available

YANG M, Zhang M, Wang Q, Guo X, et al
Six polymorphisms in the lncRNA H19 gene and the risk of cancer: a systematic review and meta-analysis.
BMC Cancer. 2023;23:688.
PubMed Abstract available

DU Q, Wu X, Zhang K, Cao F, et al
Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma.
BMC Cancer. 2023;23:681.
PubMed Abstract available

DONG H, Huang Z, Yang D, Li Z, et al
Prognostic value of EBV DNA and platelet-to-lymphocyte ratio in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
BMC Cancer. 2023;23:673.
PubMed Abstract available

KNIPPER K, Damanakis AI, Lyu SI, Simon AG, et al
High NANOG expression correlates with worse patients' survival in esophageal adenocarcinoma.
BMC Cancer. 2023;23:669.
PubMed Abstract available

WANG Z, Guan W, Ma Y, Zhou X, et al
MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/beta-catenin signaling pathway.
BMC Cancer. 2023;23:668.
PubMed Abstract available

VIENNE A, Collet L, Chevalier T, Borel C, et al
Efficacy of second-line chemotherapy or immune checkpoint inhibitors for patients with a prolonged objective response (>/= 6 months) after first-line therapy for recurrent or metastatic head and neck squamous cell carcinoma: a retrospective study.
BMC Cancer. 2023;23:663.
PubMed Abstract available

TOPKAN E, Somay E, Yilmaz B, Pehlivan B, et al
Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients.
BMC Cancer. 2023;23:651.
PubMed Abstract available

GINZAC A, Ferreira MC, Cayre A, Bouvet C, et al
Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial.
BMC Cancer. 2023;23:621.
PubMed Abstract available

June 2023

HSIEH MJ, Lo YS, Tsai YJ, Ho HY, et al
FAM13A polymorphisms are associated with a specific susceptibility to clinical progression of oral cancer in alcohol drinkers.
BMC Cancer. 2023;23:607.
PubMed Abstract available

QIU J, Yang J, Yu Y, Wang Z, et al
Prognostic value of pre-therapeutic nutritional risk factors in elderly patients with locally advanced esophageal squamous cell carcinoma receiving definitive chemoradiotherapy or radiotherapy.
BMC Cancer. 2023;23:597.
PubMed Abstract available

WANG WZ, Cao X, Bian L, Gao Y, et al
Analysis of mRNA-miRNA interaction network reveals the role of CAFs-derived exosomes in the immune regulation of oral squamous cell carcinoma.
BMC Cancer. 2023;23:591.
PubMed Abstract available

YU B, Ma SJ, Khan M, Gill J, et al
Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.
BMC Cancer. 2023;23:572.
PubMed Abstract available

HU SH, Huang MY, Chen CY, Hsieh HM, et al
Treatment patterns of targeted and nontargeted therapies and survival effects in patients with locally advanced head and neck cancer in Taiwan.
BMC Cancer. 2023;23:567.
PubMed Abstract available

ELBERS JBW, Gunsch PA, Debets R, Keereweer S, et al
HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial.
BMC Cancer. 2023;23:541.
PubMed Abstract available

DU Y, Yu X, Chang ET, Yin L, et al
EBV antibody and gastric cancer risk: a population-based nested case-control study in southern China.
BMC Cancer. 2023;23:521.
PubMed Abstract available

HUANG C, Wang M, Chen L, Wang H, et al
The pretherapeutic systemic inflammation score is a prognostic predictor for elderly patients with oesophageal cancer: a case control study.
BMC Cancer. 2023;23:505.
PubMed Abstract available

ALKANDARI AS, Ho JCY, Choi SW, Thomson P, et al
Oral cavity and oropharyngeal carcinoma disparities in age and survival in Indigenous and non-Indigenous populations of Queensland.
BMC Cancer. 2023;23:503.
PubMed Abstract available

HASSID S, Krug B, Deheneffe S, Daisne JF, et al
Treatment of supraglottic squamous cell carcinoma with advanced technologies: observational prospective evaluation of oncological outcomes, functional outcomes, quality of life and cost-effectiveness (SUPRA-QoL).
BMC Cancer. 2023;23:493.
PubMed Abstract available

May 2023

YAN S, Li FP, Jian L, Zhu HT, et al
CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
BMC Cancer. 2023;23:477.
PubMed Abstract available

AMOS A, Jiang N, Zong D, Gu J, et al
Correction: Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition.
BMC Cancer. 2023;23:462.
PubMed

YANG Z, Sun P, Dahlstrom KR, Gross N, et al
Joint effect of human papillomavirus exposure, smoking and alcohol on risk of oral squamous cell carcinoma.
BMC Cancer. 2023;23:457.
PubMed Abstract available

WANG S, Xie L, Zhuang J, Qian Y, et al
Association between use of antihypertensive drugs and the risk of cancer: a population-based cohort study in Shanghai.
BMC Cancer. 2023;23:425.
PubMed Abstract available

GAO Y, Guan L, Jia R, Xiao W, et al
High expression of PPFIA1 in human esophageal squamous cell carcinoma correlates with tumor metastasis and poor prognosis.
BMC Cancer. 2023;23:417.
PubMed Abstract available

YE G, Zhang X, Li M, Lin Z, et al
Integrated analysis of circulating and tissue proteomes reveals that fibronectin 1 is a potential biomarker in papillary thyroid cancer.
BMC Cancer. 2023;23:412.
PubMed Abstract available

HUANG YY, Zhou JY, Zhan ZJ, Ke LR, et al
Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid,
BMC Cancer. 2023;23:410.
PubMed Abstract available

AUGUSTE A, Gaete S, Michineau L, Herrmann-Storck C, et al
Association between sexual behaviour and head and neck cancer in the French West Indies: a case-control study based on an Afro-Caribbean population.
BMC Cancer. 2023;23:407.
PubMed Abstract available

YANG H, Wang JB, Wang XK, Fan JH, et al
Association between type of drinking water and upper gastrointestinal cancer incidence in the Linxian General Population.
BMC Cancer. 2023;23:397.
PubMed Abstract available

April 2023

LEE J, Nguyen NT, Wright J, Yeung KD, et al
A phase 2 study of stereotactic body radiation therapy for squamous cell carcinoma of the head and neck (SHINE): a single arm clinical trial protocol.
BMC Cancer. 2023;23:379.
PubMed Abstract available

HOLMBERG D, Gottlieb-Vedi E, Hedberg J, Lindblad M, et al
Aspirin or statin use in relation to survival after surgery for esophageal cancer: a population-based cohort study.
BMC Cancer. 2023;23:375.
PubMed Abstract available

LIU L, Lin H, Shen G, Liu Y, et al
Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma.
BMC Cancer. 2023;23:370.
PubMed Abstract available

CHEN M, Xue J, Sang Y, Jiang W, et al
Highly sensitive droplet digital PCR for detection of RET fusion in papillary thyroid cancer.
BMC Cancer. 2023;23:363.
PubMed Abstract available

SISTONEN HJ, Ilmarinen T, Atula T, Aro K, et al
PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy.
BMC Cancer. 2023;23:358.
PubMed Abstract available

MACQ G, Silversmit G, Verdoodt F, Van Eycken L, et al
The epidemiology of multiple primary cancers in Belgium (2004-2017): Incidence, proportion, risk, stage and impact on relative survival estimates.
BMC Cancer. 2023;23:349.
PubMed Abstract available

RAMEZANI V, Ghadirian S, Shabani M, Boroumand MA, et al
Efficacy of curcumin for amelioration of radiotherapy-induced oral mucositis: a preliminary randomized controlled clinical trial.
BMC Cancer. 2023;23:354.
PubMed Abstract available

ZHANG J, Lin Z, Zhou J, Huang Y, et al
Effects of preoperative albumin-to-globulin ratio on overall survival and quality of life in esophageal cell squamous carcinoma patients: a prospective cohort study.
BMC Cancer. 2023;23:342.
PubMed Abstract available

VAN DER ZIJDEN CJ, Lagarde SM, Hermus M, Kranenburg LW, et al
A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2.
BMC Cancer. 2023;23:327.
PubMed Abstract available

ZHANG P, Wang S, Wu JZ, Song Q, et al
Clinical and prognostic significance of perioperative change in red cell distribution width in patients with esophageal squamous cell carcinoma.
BMC Cancer. 2023;23:319.
PubMed Abstract available

HUANG Q, Li F, Ji M, Lin L, et al
Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study.
BMC Cancer. 2023;23:324.
PubMed Abstract available

HONG K, Yang Q, Yin H, Wei N, et al
Comprehensive analysis of ZNF family genes in prognosis, immunity, and treatment of esophageal cancer.
BMC Cancer. 2023;23:301.
PubMed Abstract available

March 2023

AKHTAR S, Al-Shammari A, Al-Huraiti M, Al-Anjery F, et al
Disparities in oesophageal cancer risk by age, sex, and nativity in Kuwait:1980-2019.
BMC Cancer. 2023;23:293.
PubMed Abstract available

SAITO Y, Hamamoto Y, Hirata K, Yamasaki M, et al
Real-world management and outcomes of older patients with locally advanced esophageal squamous cell carcinoma: a multicenter retrospective study.
BMC Cancer. 2023;23:283.
PubMed Abstract available

RODRIGUEZ-ARIETALEANIZBEASKOA , Mojas Ereno E, Arietaleanizbeaskoa MS, Grandes G, et al
Protocol for the SEHNeCa randomised clinical trial assesing Supervised Exercise for Head and Neck Cancer patients.
BMC Cancer. 2023;23:271.
PubMed Abstract available

YANG J, Huang A, Yang K, Jiang K, et al
Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial.
BMC Cancer. 2023;23:249.
PubMed Abstract available

DU Y, Yu X, Chang ET, Lian S, et al
Pre-diagnostic anti-EBV antibodies and primary liver cancer risk: a population-based nested case-control study in southern China.
BMC Cancer. 2023;23:250.
PubMed Abstract available

PERREARD M, Florent R, Divoux J, Grellard JM, et al
ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies.
BMC Cancer. 2023;23:223.
PubMed Abstract available

KAMIYA H, Komatsu S, Nishibeppu K, Ohashi T, et al
Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction.
BMC Cancer. 2023;23:218.
PubMed Abstract available

TSAI YS, Chen YC, Chen TI, Lee YK, et al
Incidence trends of oral cavity, oropharyngeal, hypopharyngeal and laryngeal cancers among males in Taiwan, 1980-2019: a population-based cancer registry study.
BMC Cancer. 2023;23:213.
PubMed Abstract available

ZHEN H, Tian J, Li G, Zhao P, et al
Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis.
BMC Cancer. 2023;23:207.
PubMed Abstract available

ZHANG Y, Zhang L, Li B, Ye T, et al
Machine learning to predict occult metastatic lymph nodes along the recurrent laryngeal nerves in thoracic esophageal squamous cell carcinoma.
BMC Cancer. 2023;23:197.
PubMed Abstract available

February 2023

LING F, Xu S, Li X, Sun X, et al
Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy.
BMC Cancer. 2023;23:190.
PubMed

XIAO H, Bertwistle D, Khela K, Middleton-Dalby C, et al
Global retrospective analysis of clinician- and patient-reported clinical characteristics and humanistic burden of patients with gastroesophageal cancers on first-line treatment.
BMC Cancer. 2023;23:186.
PubMed Abstract available

LAM LL, Pavlakis N, Shitara K, Sjoquist KM, et al
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG).
BMC Cancer. 2023;23:180.
PubMed Abstract available

LING F, Xu S, Li X, Sun X, et al
Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy.
BMC Cancer. 2023;23:169.
PubMed Abstract available

FEI Z, Hong H, Xu T, Xu Y, et al
Analysis of risk characteristics for metachronous metastasis in different period of nasopharyngeal carcinoma.
BMC Cancer. 2023;23:165.
PubMed Abstract available

XU G, Yang Y, Yang J, Xiao L, et al
Screening and identification of miR-181a-5p in oral squamous cell carcinoma and functional verification in vivo and in vitro.
BMC Cancer. 2023;23:162.
PubMed Abstract available

HUO G, Liu W, Chen P
Efficacy of PD-1/PD-L1 inhibitors in gastric or gastro-oesophageal junction cancer based on clinical characteristics: a meta-analysis.
BMC Cancer. 2023;23:143.
PubMed Abstract available

ZHANG Z, Xie C, Gao T, Yang Y, et al
Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma-an exploration of surrogate endpoint.
BMC Cancer. 2023;23:145.
PubMed Abstract available

NODA Y, Ishida M, Yamaka R, Ueno Y, et al
MMP14 expression levels accurately predict the presence of extranodal extensions in oral squamous cell carcinoma: a retrospective cohort study.
BMC Cancer. 2023;23:142.
PubMed Abstract available

WANG Z, Qu L, Chen Q, Zhou Y, et al
Deep learning-based multifeature integration robustly predicts central lymph node metastasis in papillary thyroid cancer.
BMC Cancer. 2023;23:128.
PubMed Abstract available

TSAI CY, Wen YW, Lee SR, Ng SH, et al
Early relapse is an adverse prognostic factor for survival outcomes in patients with oral cavity squamous cell carcinoma: results from a nationwide registry study.
BMC Cancer. 2023;23:126.
PubMed Abstract available

AMOS A, Jiang N, Zong D, Gu J, et al
Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition.
BMC Cancer. 2023;23:117.
PubMed Abstract available

January 2023

DING Y, Chu L, Cao Q, Lei H, et al
A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
BMC Cancer. 2023;23:45.
PubMed Abstract available

SHAO S, Scholtz LU, Gendreizig S, Martinez-Ruiz L, et al
Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytes.
BMC Cancer. 2023;23:47.
PubMed Abstract available

GAO SG, Qi ZP, Qi YJ, Hou YY, et al
Porphyromonas gingivalis predicts local recurrence after endoscopic submucosal dissection of early esophageal squamous cell carcinoma or precancerous lesion.
BMC Cancer. 2023;23:43.
PubMed Abstract available

ROOHINEJAD Z, Bahramian S, Shamsabadi FT, Sahebi R, et al
Upregulation of the c-MYC oncogene and adjacent long noncoding RNAs PVT1 and CCAT1 in esophageal squamous cell carcinoma.
BMC Cancer. 2023;23:34.
PubMed Abstract available

JIA GD, Sun XS, Li XY, Liu SL, et al
Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma.
BMC Cancer. 2023;23:7.
PubMed Abstract available

December 2022

CUI Z, Du L, Wang J, Li Z, et al
Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients.
BMC Cancer. 2022;22:1354.
PubMed Abstract available

CHEN TH, Pan YY, Lee TL, Wang LW, et al
Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma.
BMC Cancer. 2022;22:1336.
PubMed Abstract available

WANG A, Tan Y, Wang S, Chen X, et al
The prognostic value of separate lymphatic invasion and vascular invasion in oesophageal squamous cell carcinoma: a meta-analysis and systematic review.
BMC Cancer. 2022;22:1329.
PubMed Abstract available

DAY F, Sridharan S, Lynam J, Gedye C, et al
Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trial
BMC Cancer. 2022;22:1324.
PubMed Abstract available

LIU Y, Xiong R, Xiao T, Xiong L, et al
SCARA5 induced ferroptosis to effect ESCC proliferation and metastasis by combining with Ferritin light chain.
BMC Cancer. 2022;22:1304.
PubMed Abstract available

MA Y, Chen J, Yao X, Li Z, et al
Patterns and prognostic predictive value of perineural invasion in esophageal squamous cell carcinoma.
BMC Cancer. 2022;22:1287.
PubMed Abstract available

RYU YJ, Lim SY, Na YM, Park MH, et al
Prostate-specific membrane antigen expression predicts recurrence of papillary thyroid carcinoma after total thyroidectomy.
BMC Cancer. 2022;22:1278.
PubMed Abstract available

KHALES SA, Mozaffari-Jovin S, Geerts D, Abbaszadegan MR, et al
TWIST1 activates cancer stem cell marker genes to promote epithelial-mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma.
BMC Cancer. 2022;22:1272.
PubMed Abstract available

PHATAK P, Burrows WM, Creed TM, Youssef M, et al
MiR-214-3p targets Ras-related protein 14 (RAB14) to inhibit cellular migration and invasion in esophageal Cancer cells.
BMC Cancer. 2022;22:1265.
PubMed Abstract available

LI W, Yang C, Zhao F, Li J, et al
Combination of smoking and Epstein-Barr virus DNA is a predictor of poor prognosis for nasopharyngeal carcinoma: a long-term follow-up retrospective study.
BMC Cancer. 2022;22:1262.
PubMed Abstract available

BODEN A, Lusque A, Lodin S, Bourgouin M, et al
Study protocol of the TEC-ORL clinical trial: a randomized comparative phase II trial investigating the analgesic activity of capsaicin vs Laroxyl in head and neck Cancer survivors presenting with neuropathic pain sequelae.
BMC Cancer. 2022;22:1260.
PubMed Abstract available

SHEN Y, Shao Y, Ruan X, Zhu L, et al
Genetic variant in miR-17-92 cluster binding sites is associated with esophageal squamous cell carcinoma risk in Chinese population.
BMC Cancer. 2022;22:1253.
PubMed Abstract available

KANEMATSU K, Kudose Y, Utsunomiya D, Kubo K, et al
Surveillance Strategy after Curative Resection for Oesophageal Squamous Cell Cancer Using the Hazard Function.
BMC Cancer. 2022;22:1245.
PubMed Abstract available

XU S, Huang H, Huang Y, Wang X, et al
Risk stratification of lateral neck recurrence for patients with pN1a papillary thyroid cancer.
BMC Cancer. 2022;22:1246.
PubMed Abstract available

November 2022

SPRAVE T, Gkika E, Verma V, Grosu AL, et al
Patient reported outcomes based on EQ-5D-5L questionnaires in head and neck cancer patients: a real-world study.
BMC Cancer. 2022;22:1236.
PubMed Abstract available

LUO X, Huang X, Luo J, Xiao J, et al
Induction TPF followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locally advanced hypopharyngeal cancer: a preliminary analysis of a randomized phase 2 trial.
BMC Cancer. 2022;22:1235.
PubMed Abstract available

YANG XL, Zhang LL, Kou J, Zhou GQ, et al
Cisplatin-based concurrent chemoradiotherapy improved the survival of locoregionally advanced nasopharyngeal carcinoma after induction chemotherapy by reducing early treatment failure.
BMC Cancer. 2022;22:1230.
PubMed Abstract available

KAO HF, Huang HC, Liao BC, Hong RL, et al
Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis.
BMC Cancer. 2022;22:1228.
PubMed Abstract available

DUPONT M, Carlier C, Gower-Rousseau C, Barbier-Lider P, et al
Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?
BMC Cancer. 2022;22:1219.
PubMed Abstract available

CAO Y, Dong H, Li G, Wei H, et al
Temporal and spatial characteristics of tumor evolution in a mouse model of oral squamous cell carcinoma.
BMC Cancer. 2022;22:1209.
PubMed Abstract available

WANG J, Wang N, Zheng Z, Che Y, et al
Exosomal lncRNA HOTAIR induce macrophages to M2 polarization via PI3K/ p-AKT /AKT pathway and promote EMT and metastasis in laryngeal squamous cell carcinoma.
BMC Cancer. 2022;22:1208.
PubMed Abstract available

YEH TL, Hsu MS, Hsu HY, Tsai MC, et al
Risk of cardiovascular diseases in cancer patients: A nationwide representative cohort study in Taiwan.
BMC Cancer. 2022;22:1198.
PubMed Abstract available

YANG Y, Tang P, Ma M, Zhang H, et al
Comparison of clinicopathological features and prognostic significance between synchronous multiple primary and solitary esophageal squamous cell carcinomas.
BMC Cancer. 2022;22:1191.
PubMed Abstract available

YANG Z, Lin H, Wang Z, Rong L, et al
The prognostic significance of the circumferential resection margin in esophageal squamous cell carcinoma patients without neoadjuvant treatment.
BMC Cancer. 2022;22:1180.
PubMed Abstract available

KAIDA H, Yasuda T, Shiraishi O, Kato H, et al
The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma.
BMC Cancer. 2022;22:1176.
PubMed Abstract available

SAWICKI CM, Janal MN, Nicholson SJ, Wu AK, et al
Oral cancer patients experience mechanical and chemical sensitivity at the site of the cancer.
BMC Cancer. 2022;22:1165.
PubMed Abstract available

INOKAWA Y, Hayashi M, Begum S, Noordhuis MG, et al
High-risk HPV infection-associated hypermethylated genes in oropharyngeal squamous cell carcinomas.
BMC Cancer. 2022;22:1146.
PubMed Abstract available

CARPEN T, Gille E, Hammarstedt-Nordenvall L, Hansen J, et al
Occupational risk variation of nasopharyngeal cancer in the Nordic countries.
BMC Cancer. 2022;22:1130.
PubMed Abstract available

WANG L, Yao B, Yang J, Tian Z, et al
Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma.
BMC Cancer. 2022;22:1131.
PubMed Abstract available

LIU SL, Li XY, Sun XS, Peng JY, et al
Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissection.
BMC Cancer. 2022;22:1129.
PubMed Abstract available

GU P, Ling B, Ma W, Zhang J, et al
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects.
BMC Cancer. 2022;22:1116.
PubMed Abstract available

October 2022

SAADAAT R, Abdul-Ghafar J, Hanifi AN, Khalid S, et al
Risk factors associated with esophageal cancers, diagnosed at tertiary level in Afghanistan: a descriptive cross-sectional study.
BMC Cancer. 2022;22:1112.
PubMed Abstract available

ALMANGUSH A, Bello IO, Elseragy A, Hagstrom J, et al
Tertiary lymphoid structures associate with improved survival in early oral tongue cancer.
BMC Cancer. 2022;22:1108.
PubMed Abstract available

FENG Y, Wang B, Pan L, Yao B, et al
Study protocol for artificial intelligence-assisted sponge cytology as pre-endoscopy screening for early esophegeal squmaous epithelial lesions in China.
BMC Cancer. 2022;22:1105.
PubMed Abstract available

NISHIMURA A, Yokota T, Hamauchi S, Onozawa Y, et al
Prognostic impact of the number of metastatic lymph nodes after surgery in locally advanced hypopharyngeal cancer.
BMC Cancer. 2022;22:1101.
PubMed Abstract available

SHEN Y, Huang Q, Ji M, Hsueh CY, et al
Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas.
BMC Cancer. 2022;22:1093.
PubMed Abstract available

TANG CL, Tsai WC, Lee JY, Wang YK, et al
Higher pre-treatment skin sympathetic nerve activity and elevated resting heart rate after chemoradiotherapy predict worse esophageal cancer outcomes.
BMC Cancer. 2022;22:1086.
PubMed Abstract available

HUNG CJ, Kang BH, Chang KM, Kang YY, et al
Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy.
BMC Cancer. 2022;22:1084.
PubMed Abstract available

KIM SI, Woo SR, Noh JK, Lee MK, et al
Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma.
BMC Cancer. 2022;22:1077.
PubMed Abstract available

YURA M, Fukuda K, Matsuda S, Irino T, et al
Effects of let-7a microRNA and C-C chemokine receptor type 7 expression on cellular function and prognosis in esophageal squamous cell carcinoma.
BMC Cancer. 2022;22:1064.
PubMed Abstract available

September 2022

CUI D, Cui X, Xu X, Zhang W, et al
Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia.
BMC Cancer. 2022;22:1027.
PubMed Abstract available

VOTAVA M, Bartolini R, Capkova L, Smetanova J, et al
The expression profiles of CD47 in the tumor microenvironment of salivary gland cancers: a next step in histology-driven immunotherapy.
BMC Cancer. 2022;22:1021.
PubMed Abstract available

HUANG Q, Ye M, Li F, Lin L, et al
Prognostic and clinicopathological significance of transcription factor c-Jun in hypopharyngeal squamous cell carcinoma: a 3-year follow-up retrospective study.
BMC Cancer. 2022;22:1019.
PubMed Abstract available

PIEK MW, de Boer JP, van Duijnhoven F, van der Wal JE, et al
The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice.
BMC Cancer. 2022;22:1018.
PubMed Abstract available

ZHANG H, Pan E, Zhang Y, Zhao C, et al
LncRNA RPL34-AS1 suppresses the proliferation, migration and invasion of esophageal squamous cell carcinoma via targeting miR-575/ACAA2 axis.
BMC Cancer. 2022;22:1017.
PubMed Abstract available

GORPHE P, Blanchard P, Garcia GCTE, Classe M, et al
2011-2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France.
BMC Cancer. 2022;22:1000.
PubMed Abstract available

RADES D, Zwaan I, Cacicedo J, Bruchhage KL, et al
Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer - results of a randomized phase III trial (RAREST-02).
BMC Cancer. 2022;22:989.
PubMed Abstract available

GAO TT, Shan JH, Yang YX, Zhang ZW, et al
Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: a systematic review and network Meta-analysis.
BMC Cancer. 2022;22:992.
PubMed Abstract available

AHMED S, Khan S, Qureshi MA, Bukhari U, et al
Expressional variations of Kaiso: an association with pathological characteristics and field cancerization of OSCC.
BMC Cancer. 2022;22:990.
PubMed Abstract available

LIANG MX, Fei YJ, Yang K, Tang WJ, et al
Potential values of circulating tumor cell for detection of recurrence in patients of thyroid cancer: a diagnostic meta-analysis.
BMC Cancer. 2022;22:954.
PubMed Abstract available

STAUDACHER JJ, Arnold A, Kuhl AA, Potzsch M, et al
Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas.
BMC Cancer. 2022;22:953.
PubMed Abstract available

XU T, Liu X
Oleuropein inhibits invasion of squamous cell carcinoma of the head and neck through TGF-beta1 signaling pathway.
BMC Cancer. 2022;22:942.
PubMed Abstract available

August 2022

PENG C, Yi D, Zhou Y, Yao J, et al
Differential diagnosis of non-diffuse primary thyroid lymphoma and papillary thyroid carcinoma by ultrasound combined with computed tomography.
BMC Cancer. 2022;22:938.
PubMed Abstract available

WANG C, Sun G, Wang H, Dai L, et al
Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma.
BMC Cancer. 2022;22:932.
PubMed Abstract available

LIN Z, Zeng H, Xiong W, Li J, et al
Whether the infracardiac bursa protect right pleura during laparoscopic radical operation of Siewert type II adenocarcinoma of esophagogastric junction?
BMC Cancer. 2022;22:927.
PubMed Abstract available

HU ZY, Gou JX, Cai M, Zhang YE, et al
Translation and validation of M.D. Anderson Symptom Inventory-Thyroid Cancer module in Chinese thyroid cancer patients: a cross-sectional and methodological study.
BMC Cancer. 2022;22:924.
PubMed Abstract available

EL MASHED S, O'Donovan TR, Kay E, O'Grady A, et al
Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients.
BMC Cancer. 2022;22:908.
PubMed Abstract available

GONDHOWIARDJO SA, Adham M, Rachmadi L, Atmakusuma TD, et al
Immune cells markers within local tumor microenvironment are associated with EBV oncoprotein in nasopharyngeal cancer.
BMC Cancer. 2022;22:887.
PubMed Abstract available

GUO SS, Chen YZ, Liu LT, Liu RP, et al
Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma.
BMC Cancer. 2022;22:880.
PubMed Abstract available

YUAN X, Yang H, Zeng F, Zhou S, et al
Prognostic value of systemic inflammation response index in nasopharyngeal carcinoma with negative Epstein-Barr virus DNA.
BMC Cancer. 2022;22:858.
PubMed Abstract available

WANG CK, Ho CF, Niu KY, Wu CC, et al
Risk factors for rebleeding and long-term outcomes in patients with head and neck cancer bleeding: a multicenter study.
BMC Cancer. 2022;22:841.
PubMed Abstract available

July 2022

SUN R, Zhou Y, Cai Y, Shui C, et al
circ_0000045 promotes proliferation, migration, and invasion of head and neck squamous cell carcinomas via regulating HSP70 and MAPK pathway.
BMC Cancer. 2022;22:799.
PubMed Abstract available

CHEN C, Luo L, Xu C, Yang X, et al
Tumor specificity of WNT ligands and receptors reveals universal squamous cell carcinoma oncogenes.
BMC Cancer. 2022;22:790.
PubMed Abstract available

MANDIC R, Marquardt A, Terhorst P, Ali U, et al
The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC.
BMC Cancer. 2022;22:785.
PubMed Abstract available

KAWATA-SHIMAMURA Y, Eguchi H, Kawabata-Iwakawa R, Nakahira M, et al
Biomarker discovery for practice of precision medicine in hypopharyngeal cancer: a theranostic study on response prediction of the key therapeutic agents.
BMC Cancer. 2022;22:779.
PubMed Abstract available

ISSA M, Klamer BG, Mladkova N, Laliotis GI, et al
Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort.
BMC Cancer. 2022;22:767.
PubMed Abstract available

FENG WH, Chen YY, Kuo YS, Lin KH, et al
Prognostic factors associated with (18)FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment.
BMC Cancer. 2022;22:768.
PubMed Abstract available

LIN J, Qiu Y, Zheng X, Dai Y, et al
The miR-199a-5p/PD-L1 axis regulates cell proliferation, migration and invasion in follicular thyroid carcinoma.
BMC Cancer. 2022;22:756.
PubMed Abstract available

LI J, Tang LL, Ma J
Correction: Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
BMC Cancer. 2022;22:755.
PubMed

YU E, Allan AL, Sanatani M, Lewis D, et al
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial.
BMC Cancer. 2022;22:746.
PubMed Abstract available

CZAJKOWSKI M, Kaemmerer D, Sanger J, Sauter G, et al
Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies.
BMC Cancer. 2022;22:740.
PubMed Abstract available

GUO J, Yang Q, Wei S, Shao J, et al
Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
BMC Cancer. 2022;22:745.
PubMed Abstract available

PEI W, Wang C, Liao H, Chen X, et al
MRI-based random survival Forest model improves prediction of progression-free survival to induction chemotherapy plus concurrent Chemoradiotherapy in Locoregionally Advanced nasopharyngeal carcinoma.
BMC Cancer. 2022;22:739.
PubMed Abstract available

June 2022

HIRAHARA N, Matsubara T, Kaji S, Hayashi H, et al
Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer.
BMC Cancer. 2022;22:718.
PubMed Abstract available

ZHU J, Fang R, Pan Z, Qian X, et al
Circulating lymphocyte subsets are prognostic factors in patients with nasopharyngeal carcinoma.
BMC Cancer. 2022;22:716.
PubMed Abstract available

LI J, Tang LL, Ma J
Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
BMC Cancer. 2022;22:714.
PubMed Abstract available

ZHOU M, Yang W, Xuan Y, Zou W, et al
A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma: the NeoRac
BMC Cancer. 2022;22:710.
PubMed Abstract available

ALMADORI G, Coli A, De Corso E, Mele DA, et al
Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival.
BMC Cancer. 2022;22:704.
PubMed Abstract available

LIN Z, Rao W, Xiang Z, Zeng Q, et al
Characteristics and interplay of esophageal microbiota in esophageal squamous cell carcinoma.
BMC Cancer. 2022;22:696.
PubMed Abstract available

DEGUCHI S, Tanaka H, Suzuki S, Natsuki S, et al
Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.
BMC Cancer. 2022;22:699.
PubMed Abstract available

SHAVER AL, Platek ME, Singh AK, Ma SJ, et al
Effect of musculature on mortality, a retrospective cohort study.
BMC Cancer. 2022;22:688.
PubMed Abstract available

ZHOU G, Zhang S, Jin M, Hu S, et al
Comprehensive analysis reveals COPB2 and RYK associated with tumor stages of larynx squamous cell carcinoma.
BMC Cancer. 2022;22:667.
PubMed Abstract available

SHI J, Wang L, Yao N, Sun L, et al
The effect of HPV DNA and p16 status on the prognosis of patients with hypopharyngeal carcinoma: a meta-analysis.
BMC Cancer. 2022;22:658.
PubMed Abstract available

CAO Y, Han D, Yang S, Shi Y, et al
Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy).
BMC Cancer. 2022;22:650.
PubMed Abstract available

TSAI PC, Chien HC, Hsu PK, Hung JJ, et al
Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy.
BMC Cancer. 2022;22:637.
PubMed Abstract available

MAAHS L, Ghanem AI, Gutta R, Tang A, et al
Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy.
BMC Cancer. 2022;22:626.
PubMed Abstract available

LI Z, Li C, Yang D, Song J, et al
Comparing the efficacy and safety of cisplatin and other platinum-based chemotherapies in locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis.
BMC Cancer. 2022;22:616.
PubMed Abstract available

LO WC, Chang CM, Wu CY, Hsieh CH, et al
A predictive model for advanced oropharyngeal cancer patients treated with chemoradiation.
BMC Cancer. 2022;22:615.
PubMed Abstract available

NELLIGAN NM, Bender MR, Feltus FA
Simulating the restoration of normal gene expression from different thyroid cancer stages using deep learning.
BMC Cancer. 2022;22:612.
PubMed Abstract available

LUO QW, Gao S, Lv X, Li SJ, et al
A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study.
BMC Cancer. 2022;22:606.
PubMed Abstract available

May 2022

ZOU X, Zhou Q, Nie Y, Gou J, et al
Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway.
BMC Cancer. 2022;22:595.
PubMed Abstract available

CAI Z, Tang B, Chen L, Lei W, et al
Mast cell marker gene signature in head and neck squamous cell carcinoma.
BMC Cancer. 2022;22:577.
PubMed Abstract available

MANN C, Berlth F, Hadzijusufovic E, Tagkalos E, et al
Extended lower paratracheal lymph node resection during esophagectomy for cancer - safety and necessity.
BMC Cancer. 2022;22:579.
PubMed Abstract available

LIN C, Li M, Lin N, Zong J, et al
RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma.
BMC Cancer. 2022;22:549.
PubMed Abstract available

QIAN L, Ni T, Fei B, Sun H, et al
An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
BMC Cancer. 2022;22:545.
PubMed Abstract available

HUO Z, Fu S, Ma C, Sheng S, et al
Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: a retrospective cohort study.
BMC Cancer. 2022;22:535.
PubMed Abstract available

DOS SANTOS M, Lequesne J, Leconte A, Corbinais S, et al
Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR).
BMC Cancer. 2022;22:537.
PubMed Abstract available

CAI M, Zheng Z, Bai Z, Ouyang K, et al
Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers.
BMC Cancer. 2022;22:530.
PubMed Abstract available

LU XJD, Jackson E, Chew J, Nguyen S, et al
Combined chemoradiotherapy showed improved outcome with early-stage HPV-positive oropharyngeal cancers.
BMC Cancer. 2022;22:513.
PubMed Abstract available

JIN YN, Xia TL, Mai DM, Yao JJ, et al
The prognostic value of weight loss during radiotherapy among patients with nasopharyngeal carcinoma: a large-scale cohort study.
BMC Cancer. 2022;22:505.
PubMed Abstract available

YANG Y, Zhu L, Cheng Y, Liu Z, et al
Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study).
BMC Cancer. 2022;22:506.
PubMed Abstract available

QIU X, Wu H, Xu T, Xie S, et al
Reflecting on the utility of standardized uptake values on (18)F-FDG PET in nasopharyngeal carcinoma.
BMC Cancer. 2022;22:495.
PubMed Abstract available

April 2022

REN L, Li P, Li Z, Chen Q, et al
AQP9 and ZAP70 as immune-related prognostic biomarkers suppress proliferation, migration and invasion of laryngeal cancer cells.
BMC Cancer. 2022;22:465.
PubMed Abstract available

ZHANG Z, Zhang X, Yin Y, Zhao S, et al
Integrating BRAF(V600E) mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma.
BMC Cancer. 2022;22:461.
PubMed Abstract available

HERTEL M, Hagedorn L, Schmidt-Westhausen AM, Dommisch H, et al
Comparison of five-year survival rates among patients with oral squamous cell carcinoma with and without association with syphilis: a retrospective case-control study.
BMC Cancer. 2022;22:454.
PubMed Abstract available

IIDA M, McDaniel NK, Kostecki KL, Welke NB, et al
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer.
BMC Cancer. 2022;22:447.
PubMed Abstract available

RUITER LN, van Dijk BAC, Bruggink AH, Doornaert PAH, et al
Association of histological features with laryngeal squamous cell carcinoma recurrences: a population-based study of 1502 patients in the Netherlands.
BMC Cancer. 2022;22:444.
PubMed Abstract available

DALHAMMAR K, Kristensson J, Falkenback D, Rasmussen BH, et al
Symptoms, problems and quality of life in patients newly diagnosed with oesophageal and gastric cancer - a comparative study of treatment strategy.
BMC Cancer. 2022;22:434.
PubMed Abstract available

LI PC, Huang RY, Yang YC, Hsieh KP, et al
Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension - a real-world study.
BMC Cancer. 2022;22:430.
PubMed Abstract available

WANG Q, Wu Z, Zhan T, Fang S, et al
Retraction Note: Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis.
BMC Cancer. 2022;22:409.
PubMed

NODA Y, Ishida M, Ueno Y, Fujisawa T, et al
Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion.
BMC Cancer. 2022;22:402.
PubMed Abstract available

NIPP RD, Shulman E, Smith M, Brown PMC, et al
Supportive oncology care at home interventions: protocols for clinical trials to shift the paradigm of care for patients with cancer.
BMC Cancer. 2022;22:383.
PubMed Abstract available

KUBOTA K, Ito R, Narita N, Tanaka Y, et al
Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.
BMC Cancer. 2022;22:368.
PubMed Abstract available

ZHANG C, Li B, Zhang L, Chen F, et al
Clinicopathological and ultrasound features as risk stratification predictors of clinical and pathological nodal status in papillary thyroid carcinoma: a study of 748 patients.
BMC Cancer. 2022;22:354.
PubMed Abstract available

March 2022

LIU J, Lu J, Li W
Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
BMC Cancer. 2022;22:352.
PubMed Abstract available

LEE OH, Park YM, Ko SH, Lee K, et al
Synergistic association between underweight and type 2 diabetes on the development of laryngeal cancer: a national population-based retrospective cohort study.
BMC Cancer. 2022;22:345.
PubMed Abstract available

ZHANG X, Zhang X, Jia Q, Li H, et al
LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis.
BMC Cancer. 2022;22:344.
PubMed Abstract available

LIANG M, Xiao J, Chen M, Zheng B, et al
Prognostic variables for conditional survival in patients with esophageal squamous cell carcinoma who underwent minimally invasive surgery.
BMC Cancer. 2022;22:333.
PubMed Abstract available

HUANG D, Li Y, Liu N, Zhang Z, et al
Retraction Note: Identification of novel signaling components in N,N'-Dinitrosopiperazine-mediated metastasis of nasopharyngeal Carcinoma by quantitative phosphoproteomics.
BMC Cancer. 2022;22:324.
PubMed

YANG F, Sun Z, Wang D, Du T, et al
MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD.
BMC Cancer. 2022;22:308.
PubMed Abstract available

IKAWA T, Ishihara R, Matsueda K, Konishi K, et al
Influence of radiation dose and predicted tumor invasion depth on local recurrence after definitive chemoradiotherapy for stage 0-I esophageal squamous cell carcinoma: a propensity score-weighted, retrospective, observational study.
BMC Cancer. 2022;22:301.
PubMed Abstract available

WANG CP, Chen TC, Hsu WL, Hsiao JR, et al
Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common.
BMC Cancer. 2022;22:296.
PubMed Abstract available

FENG J, Wang L, Wang L, Yang X, et al
Clinical significance of Osaka prognostic score based on nutritional and inflammatory status in patients with esophageal squamous cell carcinoma.
BMC Cancer. 2022;22:284.
PubMed Abstract available

BOSCOLO-RIZZO P, D'Alessandro A, Polesel J, Borsetto D, et al
Different inflammatory blood markers correlate with specific outcomes in incident HPV-negative head and neck squamous cell carcinoma: a retrospective cohort study.
BMC Cancer. 2022;22:243.
PubMed Abstract available

PRUIJSSEN JT, Wenmakers A, Kessels RPC, Piai V, et al
Long-term cognitive, psychosocial, and neurovascular complications of unilateral head and neck irradiation in young to middle-aged adults.
BMC Cancer. 2022;22:244.
PubMed Abstract available

CHENG J, Zhang R, Yan M, Li Y, et al
Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
BMC Cancer. 2022;22:238.
PubMed Abstract available

MIDORIKAWA S, Ohtsuru A
Young people's perspectives of thyroid cancer screening and its harms after the nuclear accident in Fukushima Prefecture: a questionnaire survey indicating opt-out screening strategy of the thyroid examination as an ethical issue.
BMC Cancer. 2022;22:235.
PubMed Abstract available

KOSKINEN AI, Hemminki O, Forsti A, Hemminki K, et al
Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half century.
BMC Cancer. 2022;22:227.
PubMed Abstract available

February 2022

WANG X, Hu B, Chen J, Xie F, et al
Risk factors of esophageal fistula induced by re-radiotherapy for recurrent esophageal cancer with local primary site.
BMC Cancer. 2022;22:207.
PubMed Abstract available

YE L, Hu L, Liu W, Luo Y, et al
Correction to: Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
BMC Cancer. 2022;22:194.
PubMed

FAN X, Huang Y, Xu P, Min Y, et al
Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT.
BMC Cancer. 2022;22:178.
PubMed Abstract available

HSIEH CY, Lien MY, Lin CY, Lo WJ, et al
Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase I trial.
BMC Cancer. 2022;22:169.
PubMed Abstract available

VEEN AV, Schiffmann LM, de Groot EM, Bartella I, et al
The ISCON-trial protocol: laparoscopic ischemic conditioning prior to esophagectomy in patients with esophageal cancer and arterial calcifications.
BMC Cancer. 2022;22:144.
PubMed Abstract available

January 2022

WU LL, Zhong JD, Zhu JL, Kang L, et al
Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1-3N0M0.
BMC Cancer. 2022;22:118.
PubMed Abstract available

ZANG Z, Liu Y, Wang J, Liu Y, et al
Dietary patterns and severity of symptom with the risk of esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional latent class analysis.
BMC Cancer. 2022;22:95.
PubMed Abstract available

UENO T, Yatsuoka W, Ishiki H, Miyano K, et al
Effects of an oral mucosa protective formulation on chemotherapy- and/or radiotherapy-induced oral mucositis: a prospective study.
BMC Cancer. 2022;22:90.
PubMed Abstract available

BUCKLE GC, Mrema A, Mwachiro M, Ringo Y, et al
Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study.
BMC Cancer. 2022;22:82.
PubMed Abstract available

GILLMAN A, Hayes M, Sheaf G, Walshe M, et al
Exercise-based dysphagia rehabilitation for adults with oesophageal cancer: a systematic review.
BMC Cancer. 2022;22:53.
PubMed Abstract available

SCHLINTL V, Huemer F, Rinnerthaler G, Melchardt T, et al
Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort.
BMC Cancer. 2022;22:51.
PubMed Abstract available

LIN C, Lin S, Zhu L, Lin S, et al
Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis.
BMC Cancer. 2022;22:35.
PubMed Abstract available

ROSENBERG AJ, Izumchenko E, Pearson A, Gooi Z, et al
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment.
BMC Cancer. 2022;22:17.
PubMed Abstract available

HENNESSY MA, Hamid M, Keegan NM, Corrigan L, et al
Metastatic gastroesophageal cancer in older patients - is this patient cohort represented in clinical trials?
BMC Cancer. 2022;22:3.
PubMed Abstract available

December 2021

HUANG B, Chan EG, Pennathur A, Luketich JD, et al
The ideal approach for treatment of cT1N+ and cT2Nany esophageal cancer.: a NCDB analysis.
BMC Cancer. 2021;21:1334.
PubMed Abstract available

XIAO L, Hu Q, Peng Y, Zheng K, et al
TRAP1 suppresses oral squamous cell carcinoma progression by reducing oxidative phosphorylation metabolism of Cancer-associated fibroblasts.
BMC Cancer. 2021;21:1329.
PubMed Abstract available

OU D, Wu Y
The prognostic and clinical significance of IFI44L aberrant downregulation in patients with oral squamous cell carcinoma.
BMC Cancer. 2021;21:1327.
PubMed Abstract available

LIU LT, Guo SS, Li H, Lin C, et al
Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma.
BMC Cancer. 2021;21:1320.
PubMed Abstract available

WUSHOU A, Yibulayin F, Sheng L, Luo Y, et al
Elective neck dissection improves the survival of patients with T2N0M0 oral squamous cell carcinoma: a study of the SEER database.
BMC Cancer. 2021;21:1309.
PubMed Abstract available

XU N, Lu M, Wang J, Li Y, et al
Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway.
BMC Cancer. 2021;21:1307.
PubMed Abstract available

ZOUHRY Y, Taibi A, Durand-Fontanier S, Darbas T, et al
Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence.
BMC Cancer. 2021;21:1313.
PubMed Abstract available

REN JL, Rojo RD, Perez JVD, Yeung SJ, et al
Variations in pain prevalence, severity, and analgesic use by duration of survivorship: a cross-sectional study of 505 post-treatment head and neck cancer survivors.
BMC Cancer. 2021;21:1304.
PubMed Abstract available

PU Y, Li Q, Wang Y, Xu L, et al
pERK-mediated IL8 secretion can enhance the migration, invasion, and cisplatin resistance of CD10-positive oral cancer cells.
BMC Cancer. 2021;21:1283.
PubMed Abstract available

November 2021

SUNDE B, Lindblad M, Malmstrom M, Hedberg J, et al
Health-related quality of life one year after the diagnosis of oesophageal cancer: a population-based study from the Swedish National Registry for Oesophageal and Gastric Cancer.
BMC Cancer. 2021;21:1277.
PubMed Abstract available

ZONG JF, Liang QD, Lu QJ, Liu YH, et al
Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma.
BMC Cancer. 2021;21:1274.
PubMed Abstract available

YE L, Hu L, Liu W, Luo Y, et al
Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
BMC Cancer. 2021;21:1250.
PubMed Abstract available

ZHANG Y, Chen M, Liu Z, Wang X, et al
The neuropeptide calcitonin gene-related peptide links perineural invasion with lymph node metastasis in oral squamous cell carcinoma.
BMC Cancer. 2021;21:1254.
PubMed Abstract available

BALK M, Rupp R, Mantsopoulos K, Allner M, et al
Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
BMC Cancer. 2021;21:1236.
PubMed Abstract available

MCILVANNA E, Linden GJ, Craig SG, Lundy FT, et al
Fusobacterium nucleatum and oral cancer: a critical review.
BMC Cancer. 2021;21:1212.
PubMed Abstract available

LI J, Yan T, Wu X, Ke X, et al
Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
BMC Cancer. 2021;21:1205.
PubMed Abstract available

ZHU X, Shanzhou Q, Li D, Pang X, et al
PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis.
BMC Cancer. 2021;21:1195.
PubMed Abstract available

SHI K, Zhang JZ, Yang L, Li NN, et al
Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma.
BMC Cancer. 2021;21:1196.
PubMed Abstract available

NAGAKI Y, Motoyama S, Sato Y, Wakita A, et al
Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy.
BMC Cancer. 2021;21:1192.
PubMed Abstract available

SUZUKI H, Sasaki E, Takano G, Goto S, et al
Lymph node ratio as a predictor for minor salivary gland cancer in head and neck.
BMC Cancer. 2021;21:1186.
PubMed Abstract available

CHEN S, Lai H, Zhao J, Chen B, et al
The viral expression and immune status in human cancers and insights into novel biomarkers of immunotherapy.
BMC Cancer. 2021;21:1183.
PubMed Abstract available

October 2021

ZHU Y, Yao W, Xu BC, Lei YY, et al
Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers.
BMC Cancer. 2021;21:1167.
PubMed Abstract available

ROSVALL BR, Kostiuk M, Williams J, Matkin A, et al
Utility of droplet digital polymerase chain reaction for TERT and BRAF mutational profiling of thyroid nodules.
BMC Cancer. 2021;21:1142.
PubMed Abstract available

CHEN Y, Huang Q, Chen J, Lin Y, et al
Primary gross tumor volume is prognostic and suggests treatment in upper esophageal cancer.
BMC Cancer. 2021;21:1130.
PubMed Abstract available

KASSIR ZM, Li J, Harrison C, Johnson JT, et al
Disparity of perception of quality of life between head and neck cancer patients and caregivers.
BMC Cancer. 2021;21:1127.
PubMed Abstract available

MERINO T, Pinto MP, Orellana MP, Martinez G, et al
Multimodal assessment of acute cardiac toxicity induced by thoracic radiotherapy in cancer patients. Study protocol.
BMC Cancer. 2021;21:1114.
PubMed Abstract available

MARTINO R, Fitch MI, Fuller CD, Hope A, et al
The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer.
BMC Cancer. 2021;21:1100.
PubMed Abstract available

ZHANG QW, Wang JY, Qiao XF, Li TL, et al
Variations in disease burden of laryngeal cancer attributable to alcohol use and smoking in 204 countries or territories, 1990-2019.
BMC Cancer. 2021;21:1082.
PubMed Abstract available

ZHOU Y, Zhang S, Min Z, Yu Z, et al
Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
BMC Cancer. 2021;21:1085.
PubMed Abstract available

MUHANNA N, Eu D, Chan HHL, Douglas C, et al
Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy.
BMC Cancer. 2021;21:1075.
PubMed Abstract available

HUANG Q, Shen YJ, Hsueh CY, Guo Y, et al
miR-17-5p drives G2/M-phase accumulation by directly targeting CCNG2 and is related to recurrence of head and neck squamous cell carcinoma.
BMC Cancer. 2021;21:1074.
PubMed Abstract available

September 2021

LV X, Han S, Xu B, Deng Y, et al
The value of complete blood count for the prognosis analysis of preoperative esophageal squamous cell carcinoma.
BMC Cancer. 2021;21:1072.
PubMed Abstract available

AUGUSTE A, Joachim C, Deloumeaux J, Gaete S, et al
Head and neck cancer risk factors in the French West Indies.
BMC Cancer. 2021;21:1071.
PubMed Abstract available

KAWASHITA Y, Kitamura M, Soutome S, Ukai T, et al
Association of neutrophil-to-lymphocyte ratio with severe radiation-induced mucositis in pharyngeal or laryngeal cancer patients: a retrospective study.
BMC Cancer. 2021;21:1064.
PubMed Abstract available

CHENG S, Yang L, Dai X, Wang J, et al
The risk and prognostic factors for brain metastases in esophageal cancer patients: an analysis of the SEER database.
BMC Cancer. 2021;21:1057.
PubMed Abstract available

TAGKALOS E, van der Sluis PC, Berlth F, Poplawski A, et al
Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial).
BMC Cancer. 2021;21:1060.
PubMed Abstract available

SHI C, Liu S, Tian X, Wang X, et al
A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma.
BMC Cancer. 2021;21:1035.
PubMed Abstract available

NIU C, Liu Y, Wang J, Liu Y, et al
Risk factors for esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional study.
BMC Cancer. 2021;21:1034.
PubMed Abstract available

TANIYAMA Y, Murakami K, Yoshida N, Takahashi K, et al
Evaluating the effect of Neoadjuvant chemotherapy for esophageal Cancer using the RECIST system with shorter-axis measurements: a retrospective multicenter study.
BMC Cancer. 2021;21:1008.
PubMed Abstract available

XIA T, Tian H, Zhang K, Zhang S, et al
Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
BMC Cancer. 2021;21:1003.
PubMed Abstract available

WANG Y, Wang J, Chen Z, Ma M, et al
Analysis of the correlation between high iodized salt intake and the risk of thyroid nodules: a large retrospective study.
BMC Cancer. 2021;21:1000.
PubMed Abstract available

LI R, Pang XF, Huang ZG, Yang LH, et al
Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis.
BMC Cancer. 2021;21:996.
PubMed Abstract available

WANG ZY, Jiang YZ, Xiao W, Xue XB, et al
Prognostic impact of tumor length in esophageal Cancer: a systematic review and Meta-analysis.
BMC Cancer. 2021;21:988.
PubMed Abstract available

ISHIZU T, Eichin D, Padzik A, Tuominen S, et al
Head and neck squamous cell carcinoma cell lines have an immunomodulatory effect on macrophages independent of hypoxia and toll-like receptor 9.
BMC Cancer. 2021;21:990.
PubMed Abstract available

KHAIRAN P, Sobue T, Eshak ES, Zha L, et al
Association of dietary intakes of vitamin B12, vitamin B6, folate, and methionine with the risk of esophageal cancer: the Japan Public Health Center-based (JPHC) prospective study.
BMC Cancer. 2021;21:982.
PubMed Abstract available

CHEN YH, Chen CH, Chien CY, Su YY, et al
Overexpression of UTX promotes tumor progression in Oral tongue squamous cell carcinoma patients receiving surgical resection: a case control study.
BMC Cancer. 2021;21:979.
PubMed Abstract available

August 2021

MINESAKI A, Kai K, Kuratomi Y, Aishima S, et al
Infiltration of CD1a-positive dendritic cells in advanced laryngeal cancer correlates with unfavorable outcomes post-laryngectomy.
BMC Cancer. 2021;21:973.
PubMed Abstract available

MU G, Wang J, Liu Z, Zhang H, et al
Association between smokeless tobacco use and oral cavity cancer risk in women compared with men: a systematic review and meta-analysis.
BMC Cancer. 2021;21:960.
PubMed Abstract available

LIU Z, Liu H, Dong Q, Li H, et al
Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis.
BMC Cancer. 2021;21:951.
PubMed Abstract available

LI G, Xia YF, Huang YX, Okat D, et al
Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness.
BMC Cancer. 2021;21:944.
PubMed Abstract available

FENG G, Xu Y, Ma N, Midorikawa K, et al
Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
BMC Cancer. 2021;21:929.
PubMed Abstract available

LI X, Liu Z, Zhou W, Liu X, et al
Downregulation of CCL22 and mutated NOTCH1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression, predicting poor clinical outcome.
BMC Cancer. 2021;21:922.
PubMed Abstract available

LI MX, Sun XM, Cheng WG, Ruan HJ, et al
Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma.
BMC Cancer. 2021;21:906.
PubMed Abstract available

FUJIMA N, Andreu-Arasa VC, Meibom SK, Mercier GA, et al
Prediction of the local treatment outcome in patients with oropharyngeal squamous cell carcinoma using deep learning analysis of pretreatment FDG-PET images.
BMC Cancer. 2021;21:900.
PubMed Abstract available

MASAKI C, Sugino K, Kobayashi S, Hosoi Y, et al
Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients.
BMC Cancer. 2021;21:894.
PubMed Abstract available

ZAHID N, Zahid W, Khalid W, Azam I, et al
Resilience and its associated factors in head and neck cancer patients in Pakistan: an analytical cross-sectional study.
BMC Cancer. 2021;21:888.
PubMed Abstract available

July 2021

HE Y, Liu Z, Sheng S, Gao W, et al
Salvage surgery for patients with residual/persistent diseases after improper or insufficient treatment of oral squamous cell carcinoma: can we rectify these mistakes?
BMC Cancer. 2021;21:878.
PubMed Abstract available

ROUTILA J, Suvila K, Grenman R, Leivo I, et al
Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma.
BMC Cancer. 2021;21:868.
PubMed Abstract available

SINGH P, Bennett B, Bailey T, Taylor-Stokes G, et al
Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in Europe.
BMC Cancer. 2021;21:854.
PubMed Abstract available

CHEN W, Luo YK, Zhang Y, Song Q, et al
Ultrasound-guided implantation of radioactive (125)I seed in radioiodine refractory differentiated thyroid carcinoma.
BMC Cancer. 2021;21:834.
PubMed Abstract available

ZHU C, Gu L, Liu Z, Li J, et al
Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma.
BMC Cancer. 2021;21:836.
PubMed Abstract available

LI H, Zhang X, Yi C, He Y, et al
Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
BMC Cancer. 2021;21:835.
PubMed Abstract available

LANG K, Adeberg S, Harrabi S, Held T, et al
Adenoid cystic Carcinoma and Carbon ion Only irradiation (ACCO): Study protocol for a prospective, open, randomized, two-armed, phase II study.
BMC Cancer. 2021;21:812.
PubMed Abstract available

STRAUB M, Sigman DM, Auderset A, Ollivier J, et al
Distinct nitrogen isotopic compositions of healthy and cancerous tissue in mice brain and head&neck micro-biopsies.
BMC Cancer. 2021;21:805.
PubMed Abstract available

ZHOU YJ, Lu XF, Meng JL, Wang XY, et al
Neo-adjuvant radiation therapy provides a survival advantage in T3-T4 nodal positive gastric and gastroesophageal junction adenocarcinoma: a SEER database analysis.
BMC Cancer. 2021;21:771.
PubMed Abstract available

June 2021

HE G, Pang R, Han J, Jia J, et al
TINCR inhibits the proliferation and invasion of laryngeal squamous cell carcinoma by regulating miR-210/BTG2.
BMC Cancer. 2021;21:753.
PubMed Abstract available

ITO T, Tsukahara K, Sato H, Shimizu A, et al
Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaise.
BMC Cancer. 2021;21:742.
PubMed Abstract available

MIYAWAKI Y, Sato H, Oya S, Sugita H, et al
Clinical impact of abdominal versus mediastinal metastases as a prognostic factor for poor outcomes following esophageal cancer surgery: a retrospective study.
BMC Cancer. 2021;21:725.
PubMed Abstract available

LIU C, Zhou X, Pan Y, Liu Y, et al
Pyruvate carboxylase promotes thyroid cancer aggressiveness through fatty acid synthesis.
BMC Cancer. 2021;21:722.
PubMed Abstract available

SANTERO M, Perez-Bracchiglione J, Acosta-Dighero R, Meade AG, et al
Efficacy of systemic oncological treatments in patients with advanced esophageal or gastric cancers at high risk of dying in the middle and short term: an overview of systematic reviews.
BMC Cancer. 2021;21:712.
PubMed Abstract available

BAKOS B, Kiss A, Arvai K, Szili B, et al
Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden.
BMC Cancer. 2021;21:706.
PubMed Abstract available

SHI Y, Yang D, Qin Y
Identifying prognostic lncRNAs based on a ceRNA regulatory network in laryngeal squamous cell carcinoma.
BMC Cancer. 2021;21:705.
PubMed Abstract available

UEHARA K, Tanabe Y, Hirota S, Higa S, et al
Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage.
BMC Cancer. 2021;21:688.
PubMed Abstract available

FU JY, Zhang CP, Zhang ZY
Tracking the dropout patients of neoadjuvant chemotherapy with locally advanced oral cavity cancer.
BMC Cancer. 2021;21:663.
PubMed Abstract available

DRAGAN T, Duprez F, Van Gossum A, Gulyban A, et al
Prophylactic gastrostomy in locally advanced head and neck cancer: results of a national survey among radiation oncologists.
BMC Cancer. 2021;21:656.
PubMed Abstract available

HOXHAJ I, Vukovic V, Boccia S, Pastorino R, et al
Single nucleotide polymorphisms and the risk of developing a second primary cancer among head and neck cancer patients: a systematic literature review and meta-analysis.
BMC Cancer. 2021;21:660.
PubMed Abstract available

CHEN WJ, Xu WN, Wang HY, Chen XX, et al
Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population.
BMC Cancer. 2021;21:651.
PubMed Abstract available

May 2021

LIU W, Yu B, Luo Y, Li J, et al
Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
BMC Cancer. 2021;21:639.
PubMed Abstract available

HEFT NEAL ME, Birkeland AC, Bhangale AD, Zhai J, et al
Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene.
BMC Cancer. 2021;21:636.
PubMed Abstract available

LI X, Fang Q, Du W, Zhang X, et al
Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma.
BMC Cancer. 2021;21:622.
PubMed Abstract available

MUKHERJEE K, Sur D, Singh A, Rai S, et al
Robust expression of LINE-1 retrotransposon encoded proteins in oral squamous cell carcinoma.
BMC Cancer. 2021;21:628.
PubMed Abstract available

FANG X, Wang S, Zhao J, Zhang Y, et al
A population-based analysis of clinical features and lymph node dissection in head and neck malignant neurogenic tumors.
BMC Cancer. 2021;21:598.
PubMed Abstract available

CHEN Y, Hu N, Liao L, Yu K, et al
ABO genotypes and the risk of esophageal and gastric cancers.
BMC Cancer. 2021;21:589.
PubMed Abstract available

O'CONNOR L, Smyth E, Bennett AE, Smith V, et al
Identifying outcomes reported in exercise interventions in oesophagogastric cancer survivors: a systematic review.
BMC Cancer. 2021;21:586.
PubMed Abstract available

MAGHSOOMI Z, Emami Z, Malboosbaf R, Malek M, et al
Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review.
BMC Cancer. 2021;21:579.
PubMed Abstract available

QUINTANILHA JCF, Cursino MA, Borges JB, Torso NG, et al
MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer.
BMC Cancer. 2021;21:575.
PubMed Abstract available

QIN M, Han F, Wu J, Gao FX, et al
KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPbeta transcription.
BMC Cancer. 2021;21:559.
PubMed Abstract available

GURIZZAN C, Lorini L, Paderno A, Tomasoni M, et al
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial.
BMC Cancer. 2021;21:561.
PubMed Abstract available

MEI X, Yao X, Feng F, Cheng W, et al
Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients.
BMC Cancer. 2021;21:543.
PubMed Abstract available

BEYENE ET, Ketema SG, Alebachew AN, Saleh MY, et al
Descriptive epidemiology of nasopharyngeal carcinoma at Tikur Anbessa Hospital, Ethiopia.
BMC Cancer. 2021;21:540.
PubMed Abstract available

YANG JH, Sun XS, Xiao BB, Liu LT, et al
Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy.
BMC Cancer. 2021;21:534.
PubMed Abstract available

CHEN J, Xia YJ, Liu TY, Lai YH, et al
Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.
BMC Cancer. 2021;21:532.
PubMed Abstract available

XU Y, Wu Z, Ye W, Xiao Y, et al
Prognostic value of serum uric acid and tumor response to induction chemotherapy in locally advanced nasopharyngeal carcinoma.
BMC Cancer. 2021;21:519.
PubMed Abstract available

ARSA L, Siripoon T, Trachu N, Foyhirun S, et al
Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.
BMC Cancer. 2021;21:504.
PubMed Abstract available

April 2021

ALMANGUSH A, Alabi RO, Troiano G, Coletta RD, et al
Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review and meta-analysis.
BMC Cancer. 2021;21:480.
PubMed Abstract available

ZHANG X, Song X, Lai Y, Zhu B, et al
Identification of key pseudogenes in nasopharyngeal carcinoma based on RNA-Seq analysis.
BMC Cancer. 2021;21:483.
PubMed Abstract available

KUNZ V, Wichmann G, Lehmann-Laue A, Mehnert-Theuerkauf A, et al
Screening for distress, related problems and perceived need for psycho-oncological support in head and neck squamous cell carcinoma (HNSCC) patients: a retrospective cohort study.
BMC Cancer. 2021;21:478.
PubMed Abstract available

JENSEN CB, Saucke MC, Pitt SC
Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation.
BMC Cancer. 2021;21:471.
PubMed Abstract available

WONG TJ, Li Q, Dodd V, Wang W, et al
Oral cancer knowledge and screening behavior among smokers and non-smokers in rural communities.
BMC Cancer. 2021;21:430.
PubMed Abstract available

DUAN X, Shang X, Yue J, Ma Z, et al
A nomogram to predict lymph node metastasis risk for early esophageal squamous cell carcinoma.
BMC Cancer. 2021;21:431.
PubMed Abstract available

ZHOU LQ, Hu Y, Xiao HJ
The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis.
BMC Cancer. 2021;21:424.
PubMed Abstract available

DING Y, Jiang R, Chen Y, Jing J, et al
Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: a population-based study.
BMC Cancer. 2021;21:420.
PubMed Abstract available

WEI M, Zhao L, Lv J, Li X, et al
The mediation effect of serum metabolites on the relationship between long-term smoking exposure and esophageal squamous cell carcinoma.
BMC Cancer. 2021;21:415.
PubMed Abstract available

BOGUSZEWICZ L, Bielen A, Jarczewski JD, Ciszek M, et al
Molecular response to induction chemotherapy and its correlation with treatment outcome in head and neck cancer patients by means of NMR-based metabolomics.
BMC Cancer. 2021;21:410.
PubMed Abstract available

SAENTHAVEESUK P, Yang L, Zeng B, Xu M, et al
Development and validation of multiparametric MRI-based nomogram for predicting occult metastasis risk in early tongue squamous cell carcinoma.
BMC Cancer. 2021;21:408.
PubMed Abstract available

WANG Y, Zhang X, Zhang X, Liu-Helmersson J, et al
Prognostic value of the extent of lymphadenectomy for esophageal cancer-specific survival among T1 patients.
BMC Cancer. 2021;21:403.
PubMed Abstract available

ZHOU Z, Wu W, Li J, Liu C, et al
Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma.
BMC Cancer. 2021;21:395.
PubMed Abstract available

BERNADACH M, Lapeyre M, Dillies AF, Miroir J, et al
Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
BMC Cancer. 2021;21:360.
PubMed Abstract available

NIE Z, Zhao P, Shang Y, Sun B, et al
Nomograms to predict the prognosis in locally advanced oral squamous cell carcinoma after curative resection.
BMC Cancer. 2021;21:372.
PubMed Abstract available

ZHU Q, Xu D
Correlation between preoperative ultrasonic features of medullary thyroid carcinoma and postoperative recurrence.
BMC Cancer. 2021;21:344.
PubMed Abstract available

ZHENG W, Chen C, Yu J, Jin C, et al
An energy metabolism-based eight-gene signature correlates with the clinical outcome of esophagus carcinoma.
BMC Cancer. 2021;21:345.
PubMed Abstract available

March 2021

CHOI KH, Song JH, Park EY, Hong JH, et al
Analysis of PET parameters as prognosticators of survival and tumor extent in Oropharyngeal Cancer treated with surgery and postoperative radiotherapy.
BMC Cancer. 2021;21:317.
PubMed Abstract available

PHAM DX, Nguyen HD, Phung AHT, Bui TD, et al
Trends in incidence and histological pattern of thyroid cancer in Ho Chi Minh City, Vietnam (1996-2015): a population-based study.
BMC Cancer. 2021;21:296.
PubMed Abstract available

LI C, Tao C, Bai T, Li Z, et al
Beam complexity and monitor unit efficiency comparison in two different volumetric modulated arc therapy delivery systems using automated planning.
BMC Cancer. 2021;21:261.
PubMed Abstract available

ZHANG S, Zhang R, Wang C, Gong W, et al
Central neck lymph node metastasis in oral squamous cell carcinoma at the floor of mouth.
BMC Cancer. 2021;21:225.
PubMed Abstract available

February 2021

CHOI SY, Lee E, Kim E, Chung MK, et al
Clinical outcomes of bulky parotid gland cancers: need for self-examination and screening program for early diagnosis of parotid tumors.
BMC Cancer. 2021;21:178.
PubMed Abstract available

WENTER V, Albert NL, Ahmaddy F, Unterrainer M, et al
The diagnostic challenge of coexistent sarcoidosis and thyroid cancer - a retrospective study.
BMC Cancer. 2021;21:139.
PubMed Abstract available

LIANG YJ, Mei XY, Zeng B, Zhang SE, et al
Prognostic role of preoperative D-dimer, fibrinogen and platelet levels in patients with oral squamous cell carcinoma.
BMC Cancer. 2021;21:122.
PubMed Abstract available

January 2021

KONDO S, Hirakawa H, Ikegami T, Uehara T, et al
Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma.
BMC Cancer. 2021;21:87.
PubMed Abstract available

SOLIS-PAZMINO P, Salazar-Vega J, Lincango-Naranjo E, Garcia C, et al
Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador.
BMC Cancer. 2021;21:42.
PubMed Abstract available

December 2020

KATAGIRI T, Ohyama Y, Miyamoto H, Egawa Y, et al
Pathological responses to low-dose irradiation and Pepleomycin in Oral squamous cell carcinoma are predictive of Locoregional control.
BMC Cancer. 2020;20:1216.
PubMed Abstract available

DATAR S, Cabanillas M, Dadu R, Ost D, et al
Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents.
BMC Cancer. 2020;20:1181.
PubMed Abstract available

November 2020

KALISZEWSKI K, Diakowska D, Nowak L, Wojtczak B, et al
The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice.
BMC Cancer. 2020;20:1166.
PubMed Abstract available

XIE Z, Li X, He Y, Wu S, et al
Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods.
BMC Cancer. 2020;20:1143.
PubMed Abstract available

KANG HY, Kim I, Kim YY, Bahk J, et al
Income differences in screening, incidence, postoperative complications, and mortality of thyroid cancer in South Korea: a national population-based time trend study.
BMC Cancer. 2020;20:1096.
PubMed Abstract available

October 2020

GU B, Fang Q, Wu Y, Du W, et al
Impact of submandibular gland preservation in neck management of early-stage buccal squamous cell carcinoma on locoregional control and disease-specific survival.
BMC Cancer. 2020;20:1034.
PubMed Abstract available

HOSHINO I, Nabeya Y, Takiguchi N, Gunji H, et al
Inducing multiple antibodies to treat squamous cell esophageal carcinoma.
BMC Cancer. 2020;20:1007.
PubMed Abstract available

AN YZ, Cho E, Ling J, Zhang X, et al
The Axin2-snail axis promotes bone invasion by activating cancer-associated fibroblasts in oral squamous cell carcinoma.
BMC Cancer. 2020;20:987.
PubMed Abstract available

ZHU L, Dong L, Feng M, Yang F, et al
Profiles of autophagy-related genes in esophageal adenocarcinoma.
BMC Cancer. 2020;20:943.
PubMed Abstract available

September 2020

ELHALAWANI H, Mohamed ASR, Elgohari B, Lin TA, et al
Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
BMC Cancer. 2020;20:912.
PubMed Abstract available

IZKHAKOV E, Keinan-Boker L, Barchana M, Shacham Y, et al
Long-term all-cause mortality and its association with cardiovascular risk factors in thyroid cancer survivors: an Israeli population-based study.
BMC Cancer. 2020;20:892.
PubMed Abstract available

LORENZEN S, Biederstadt A, Ronellenfitsch U, Reissfelder C, et al
RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV.
BMC Cancer. 2020;20:886.
PubMed Abstract available

YOON JY, Brezden-Masley C, Streutker CJ
Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma - significance of potentially retained stemness.
BMC Cancer. 2020;20:860.
PubMed Abstract available

ALMANGUSH A, Makitie AA, Hagstrom J, Haglund C, et al
Cell-in-cell phenomenon associates with aggressive characteristics and cancer-related mortality in early oral tongue cancer.
BMC Cancer. 2020;20:843.
PubMed Abstract available

August 2020

ZHANG B, Gao S, Li R, Li Y, et al
Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
BMC Cancer. 2020;20:815.
PubMed Abstract available

TU XP, Li H, Chen LS, Luo XN, et al
OTX1 exerts an oncogenic role and is negatively regulated by miR129-5p in laryngeal squamous cell carcinoma.
BMC Cancer. 2020;20:794.
PubMed Abstract available

ZENG H, Song X, Ji J, Chen L, et al
HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC.
BMC Cancer. 2020;20:796.
PubMed Abstract available

CHEN C, Chen S, Cao H, Wang J, et al
Prognostic significance of autophagy-related genes within esophageal carcinoma.
BMC Cancer. 2020;20:797.
PubMed Abstract available

LEERS JM, Knepper L, van der Veen A, Schroder W, et al
The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
BMC Cancer. 2020;20:781.
PubMed Abstract available

CIAPPUCCINI R, Heutte N, Lasne-Cardon A, Saguet-Rysanek V, et al
Tumor burden of persistent disease in patients with differentiated thyroid cancer: correlation with postoperative risk-stratification and impact on outcome.
BMC Cancer. 2020;20:765.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.